Holger Fuchs

1.1k total citations
32 papers, 876 citations indexed

About

Holger Fuchs is a scholar working on Oncology, Cellular and Molecular Neuroscience and Ophthalmology. According to data from OpenAlex, Holger Fuchs has authored 32 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Ophthalmology. Recurrent topics in Holger Fuchs's work include Retinal Diseases and Treatments (7 papers), Peptidase Inhibition and Analysis (7 papers) and Diabetes Treatment and Management (7 papers). Holger Fuchs is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Peptidase Inhibition and Analysis (7 papers) and Diabetes Treatment and Management (7 papers). Holger Fuchs collaborates with scholars based in Germany, Japan and United States. Holger Fuchs's co-authors include Andreas Greischel, Wolfgang Hauber, Rudolf Binder, Frank Runge, Brian D. Guth, Herbert Nar, Frank Himmelsbach, Ralf Lotz, Peter Sieger and Waldemar Pfrengle and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Holger Fuchs

32 papers receiving 857 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holger Fuchs Germany	15	417	374	289	263	101	32	876
Shoji Takakura Japan	16	253 0.6×	52 0.1×	70 0.2×	297 1.1×	169 1.7×	51	803
Qing Zhai China	18	73 0.2×	117 0.3×	101 0.3×	377 1.4×	87 0.9×	60	869
Shin-ichiro Miura United States	18	277 0.7×	42 0.1×	254 0.9×	743 2.8×	97 1.0×	22	1.3k
Yasushi Ito Japan	18	71 0.2×	157 0.4×	62 0.2×	365 1.4×	172 1.7×	51	1.1k
M. Lecomte France	15	106 0.3×	93 0.2×	85 0.3×	342 1.3×	153 1.5×	37	982
Young‐Sook Kang South Korea	12	64 0.2×	246 0.7×	87 0.3×	262 1.0×	53 0.5×	15	701
Toshie Kambe Japan	17	121 0.3×	131 0.4×	131 0.5×	373 1.4×	32 0.3×	29	784
Eunice Yuen United States	18	73 0.2×	211 0.6×	97 0.3×	320 1.2×	162 1.6×	47	872
R. Ouedraogo Belgium	16	184 0.4×	59 0.2×	101 0.3×	456 1.7×	241 2.4×	27	1.6k
Braydon L. Burgess Canada	13	125 0.3×	300 0.8×	89 0.3×	457 1.7×	535 5.3×	16	1.1k

Countries citing papers authored by Holger Fuchs

Since Specialization

Citations

This map shows the geographic impact of Holger Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Fuchs more than expected).

Fields of papers citing papers by Holger Fuchs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Fuchs. The network helps show where Holger Fuchs may publish in the future.

Co-authorship network of co-authors of Holger Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Fuchs. A scholar is included among the top collaborators of Holger Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Fuchs. Holger Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Linzhi, et al.. (2024). A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK Study. Pharmaceuticals. 17(2). 193–193. 2 indexed citations

Kaiser, Peter K., Andrea Giani, Holger Fuchs, Victor Chong, & Jeffrey S. Heier. (2023). Factors That Can Prolong Ocular Treatment Duration in Age-Related Macular Degeneration. Ophthalmic Research. 66(1). 653–663. 4 indexed citations

Tezuka, Kenta, et al.. (2022). Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs. Pharmaceutical Research. 39(7). 1393–1413. 8 indexed citations

Becker, Kolja, Carina Marianne Weigelt, Holger Fuchs, et al.. (2022). Transcriptome analysis of AAV-induced retinopathy models expressing human VEGF, TNF-α, and IL-6 in murine eyes. Scientific Reports. 12(1). 19395–19395. 3 indexed citations

Weigelt, Carina Marianne, Nina Zippel, Holger Fuchs, et al.. (2022). Characterization and Validation of In Vitro and In Vivo Models to Investigate TNF-α-Induced Inflammation in Retinal Diseases. Translational Vision Science & Technology. 11(5). 18–18. 8 indexed citations

Fuchs, Holger, Linzhi Chen, Sarah Löw, & Hongbin Yu. (2021). Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys – Evidence for half-life extension by albumin. Experimental Eye Research. 205. 108486–108486. 12 indexed citations

Rosenbrock, Holger, Riccardo Giovannini, Gerhard Schänzle, et al.. (2019). The Novel Phosphodiesterase 9A Inhibitor BI 409306 Increases Cyclic Guanosine Monophosphate Levels in the Brain, Promotes Synaptic Plasticity, and Enhances Memory Function in Rodents. Journal of Pharmacology and Experimental Therapeutics. 371(3). 633–641. 27 indexed citations

Fuchs, Holger & Frederik H. Igney. (2017). Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies. Journal of Ocular Pharmacology and Therapeutics. 33(2). 115–122. 24 indexed citations

Sakamoto, Atsushi, Holger Fuchs, Naoki Ishiguro, et al.. (2017). Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates. Molecular Pharmaceutics. 14(10). 3436–3447. 44 indexed citations

10.

Schnell, David, Holger Fuchs, Dietmar Ganßer, et al.. (2014). Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment. Cancer Chemotherapy and Pharmacology. 74(2). 267–275. 32 indexed citations

11.

Fuchs, Holger, Frank Runge, & Heinz‐Dieter Held. (2011). Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux. European Journal of Pharmaceutical Sciences. 45(5). 533–538. 26 indexed citations

12.

Chaykovska, Lyubov, Karoline von Websky, Markus Alter, et al.. (2011). Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy. PLoS ONE. 6(11). e27861–e27861. 74 indexed citations

13.

Fuchs, Holger, et al.. (2010). Modellierung des Einflusses der Verschleißverteilung auf die Beanspruchung von Fahrwerksgelenken*. Materials Testing. 52(7-8). 463–469. 1 indexed citations

14.

Retlich, Silke, et al.. (2009). Binding to dipeptidyl peptidase‐4 determines the disposition of linagliptin (BI 1356) – investigations in DPP‐4 deficient and wildtype rats. Biopharmaceutics & Drug Disposition. 30(8). 422–436. 43 indexed citations

15.

Fuchs, Holger, Rudolf Binder, & Andreas Greischel. (2009). Tissue distribution of the novel DPP‐4 inhibitor BI 1356 is dominated by saturable binding to its target in rats. Biopharmaceutics & Drug Disposition. 30(5). 229–240. 87 indexed citations

16.

Fuchs, Holger, Jean‐Paul Tillement, Saı̈k Urien, Andreas Greischel, & Willy Roth. (2008). Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans. Journal of Pharmacy and Pharmacology. 61(1). 55–62. 10 indexed citations

17.

Fuchs, Holger, Jens Nagel, & Wolfgang Hauber. (2005). Effects of physiological and pharmacological stimuli on dopamine release in the rat globus pallidus. Neurochemistry International. 47(7). 474–481. 16 indexed citations

18.

Fuchs, Holger & Wolfgang Hauber. (2003). Reverse microdialysis of ionotropic glutamate receptor agonists in the rat globus pallidus increased extracellular dopamine. Neuroscience Letters. 343(1). 37–40. 2 indexed citations

19.

Fuchs, Holger & Wolfgang Hauber. (2003). Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry. Experimental Brain Research. 154(1). 66–75. 24 indexed citations

20.

Fuchs, Holger, et al.. (1998). Subchronic Intravenous Toxicity Studies with γ-Cyclodextrin in Rats. Regulatory Toxicology and Pharmacology. 27(2). 189–198. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact